Skip to content
AnalystLens

CARDINAL HEALTH INC 8-K Report, Corporate Update (Aug 14, 2025)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed August 14, 2025
Period End
August 13, 2025
Security
CAH
In the record · 2016–202610-K1110-Q328-K120

CAH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 120 current reports (8-K) between 2016 and 2026.

  1. Restructuring8-K · Oct ’17Oct ’17
  2. Leadership change8-K · Aug ’20Aug ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Material agreement8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed August 14, 2025. Cited figures are marked; the original filing is the authoritative source.

Cardinal Health, Inc. (CAH) announced on August 13, 2025, that it has entered into an underwriting agreement to issue and sell a significant amount of senior notes.

This offering comprises $600 milliona in 4.500% Notes due 2030 and $400 million in 5.150% Notes due 2035, totaling $1 billion in aggregate principal. The issuance is being conducted under a previously effective registration statement filed with the SEC. This debt financing represents a strategic move by Cardinal Health to potentially fund its operations, investments, or refinance existing debt.

Investors should note the coupon rates and maturity dates of these new notes, which provide insights into the company's cost of capital and its long-term financial strategy. The aggregate size of the offering indicates a substantial capital raise, and the specific terms will be detailed in the filed underwriting agreement.

02—Key points

Key Highlights

  1. Cardinal Health to issue $1 billion in aggregate principal amount of senior notes.
  2. The offering includes $600 million of 4.500% Notes due 2030.
  3. The offering also includes $400 million of 5.150% Notes due 2035.
  4. The issuance is being conducted under an effective registration statement on Form S-3ASR.
  5. The underwriting agreement was entered into on August 13, 2025.
  6. Key underwriters include Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC.

03—Questions

Frequently Asked Questions

  1. What is the purpose of this debt offering?

    The filing does not explicitly state the purpose of the debt offering. However, companies typically issue debt to fund general corporate purposes, such as capital expenditures, acquisitions, working capital needs, or to refinance existing debt obligations.

  2. What are the terms of the new notes being issued?

    Cardinal Health is issuing two series of notes: $600 million aggregate principal amount of 4.500% Notes due 2030 and $400 million aggregate principal amount of 5.150% Notes due 2035. These represent the interest rates (coupon rates) and the maturity dates for these debt instruments.

  3. Where can I find more details about the underwriting agreement?

    The Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. Investors can access the full text of the agreement through the SEC's EDGAR database or through Cardinal Health's investor relations website for more comprehensive details.

  4. Does this offering impact Cardinal Health's existing debt?

    This filing indicates a new issuance of debt. While not explicitly stated, such an offering could be used to refinance existing debt that may have higher interest rates or earlier maturity dates, or it could increase the company's overall leverage.

04—Continue

← View all 8-K filings